Prescriber Insights | Clinical Updates & CE

CE & Training

NEW COURSE: Natural Medicines for Management of Type 2 Diabetes

CME-IN-THE-LETTER: Prescriber Insights February 2026

LIVE CE: GLP-1 Agonists: Clinical Conundrums and Expert Answers

PODCAST CE: Medication Talk - Smoking and Vaping Cessation

GO TO CE & TRAINING ORGANIZER

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

February 2026 Issue

Explain How New ORAL Semaglutide Stacks Up for Weight Loss

Patients are asking about Rx semaglutide tablets (Wegovy), the first ORAL GLP-1 agonist FDA approved for obesity and overweight...

Resources

Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart
Chart: Comparison of Weight Loss Products

Be Prepared With Guidance About Childhood Immunizations

Changes to the CDC childhood vaccine schedule are causing confusion...

Set the Record Straight With Menopausal Hormone Therapy

Patients will ask you about menopausal hormone therapy (MHT)...

Clear the Air With New COPD Guidelines

Updated COPD guidelines suggest starting daily inhalers sooner...

GO TO FULL ISSUE

GO TO FULL PODCAST >

Stay current with Prescriber Insights

Evidence-based updates, prescribing pearls, and monthly CE to support confident, informed therapy decisions. Learn more

Group Purchases & Pricing

Prescriber Insights is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information